| 532 | Humans (MeSH) |
| 532 | Animals (MeSH) |
| 483 | Cats (MeSH) |
| 174 | Dogs (MeSH) |
| 172 | Female (MeSH) |
| 146 | Male (MeSH) |
| 97 | Adult (MeSH) |
| 64 | France (MeSH) |
| 63 | Middle Aged (MeSH) |
| 58 | Mice (MeSH) |
| 56 | Child (MeSH) |
| 52 | Rats (MeSH) |
| 46 | Aged (MeSH) |
| 41 | Cattle (MeSH) |
| 40 | Adolescent (MeSH) |
| 38 | Cat Diseases (epidemiology) |
| 37 | France (epidemiology) |
| 31 | Risk Factors (MeSH) |
| 30 | Rabbits (MeSH) |
| 26 | Disease Models, Animal (MeSH) |
| 26 | Bartonella henselae (isolation & purification) |
| 25 | Animals, Domestic (MeSH) |
| 24 | Molecular Sequence Data (MeSH) |
| 24 | Dog Diseases (epidemiology) |
| 24 | Child, Preschool (MeSH) |
| 24 | Allergens (immunology) |
| 23 | Retrospective Studies (MeSH) |
| 22 | Species Specificity (MeSH) |
| 22 | Rabies (epidemiology) |
| 22 | Infant (MeSH) |
| 21 | Rabies (prevention & control) |
| 21 | Cat-Scratch Disease (diagnosis) |
| 20 | Surveys and Questionnaires (MeSH) |
| 20 | Cat Diseases (transmission) |
| 20 | Anti-Bacterial Agents (therapeutic use) |
| 19 | Sheep (MeSH) |
| 18 | Swine (MeSH) |
| 18 | Prevalence (MeSH) |
| 18 | Cat Diseases (MeSH) |
| 17 | Zoonoses (MeSH) |
| 17 | Cat Diseases (parasitology) |
| 17 | Base Sequence (MeSH) |
| 16 | Young Adult (MeSH) |
| 16 | Polymerase Chain Reaction (MeSH) |
| 16 | History, 20th Century (MeSH) |
| 16 | Guinea Pigs (MeSH) |
| 15 | Phylogeny (MeSH) |
| 15 | Cat-Scratch Disease (microbiology) |
| 15 | Cat Diseases (microbiology) |
| 15 | Bartonella Infections (microbiology) |
| 15 | Amino Acid Sequence (MeSH) |
| 14 | Treatment Outcome (MeSH) |
| 14 | Seroepidemiologic Studies (MeSH) |
| 14 | Pregnancy (MeSH) |
| 14 | Immunoglobulin E (blood) |
| 14 | Cell Line (MeSH) |
| 14 | Bites and Stings (epidemiology) |
| 14 | Bartonella henselae (genetics) |
| 14 | Asthma (immunology) |
| 14 | Aged, 80 and over (MeSH) |
| 13 | Incidence (MeSH) |
| 13 | Bites and Stings (complications) |
| 12 | Time Factors (MeSH) |
| 12 | Rabies Vaccines (MeSH) |
| 12 | Prospective Studies (MeSH) |
| 12 | Infant, Newborn (MeSH) |
| 12 | Haplorhini (MeSH) |
| 12 | Evolution, Molecular (MeSH) |
| 12 | Asthma (epidemiology) |
| 11 | Toxoplasma (genetics) |
| 11 | Phenotype (MeSH) |
| 11 | DNA, Bacterial (genetics) |
| 11 | DNA, Bacterial (analysis) |
| 11 | Cricetinae (MeSH) |
| 10 | Zoonoses (transmission) |
| 10 | Toxoplasmosis (epidemiology) |
| 10 | Sleep (physiology) |
| 10 | Skin Tests (MeSH) |
| 10 | Sequence Analysis, DNA (MeSH) |
| 10 | Pasteurella multocida (isolation & purification) |
| 10 | History, 21st Century (MeSH) |
| 10 | Dog Diseases (MeSH) |
| 10 | Disease Vectors (MeSH) |
| 10 | Cats (immunology) |
| 10 | Cat Diseases (virology) |
| 10 | Cat Diseases (diagnosis) |
| 10 | Asthma (etiology) |
| 10 | Allergens (adverse effects) |
| 9 | Vaccination (MeSH) |
| 9 | In Vitro Techniques (MeSH) |
| 9 | Immunoglobulin E (immunology) |
| 9 | Horses (MeSH) |
| 9 | Foxes (MeSH) |
| 9 | Europe (epidemiology) |
| 9 | Environmental Exposure (MeSH) |
| 9 | Dog Diseases (transmission) |
| 9 | Dog Diseases (parasitology) |
| 9 | Disease Reservoirs (MeSH) |
| 9 | Cross-Sectional Studies (MeSH) |
| 9 | Cats (microbiology) |
| 9 | Cat-Scratch Disease (complications) |
| 9 | Age Factors (MeSH) |
| 8 | Zoonoses (epidemiology) |
| 8 | Wound Infection (microbiology) |
| 8 | Toxoplasmosis (parasitology) |
| 8 | Rabies Vaccines (administration & dosage) |
| 8 | Pollen (immunology) |
| 8 | Models, Neurological (MeSH) |
| 8 | Hypersensitivity (immunology) |
| 8 | History, 19th Century (MeSH) |
| 8 | Genotype (MeSH) |
| 8 | Genetic Variation (MeSH) |
| 8 | Europe (MeSH) |
| 8 | Dog Diseases (microbiology) |
| 8 | Cats (anatomy & histology) |
| 8 | Case-Control Studies (MeSH) |
| 8 | Bartonella Infections (epidemiology) |
| 8 | Bartonella Infections (diagnosis) |
| 8 | Animals, Wild (MeSH) |
| 8 | Allergens (MeSH) |
| 7 | Zoonoses (microbiology) |
| 7 | United States (MeSH) |
| 7 | Tumor Cells, Cultured (MeSH) |
| 7 | Toxoplasma (immunology) |
| 7 | Sleep, REM (physiology) |
| 7 | Sensitivity and Specificity (MeSH) |
| 7 | Rabies (veterinary) |
| 7 | RNA, Ribosomal, 16S (genetics) |
| 7 | Pasteurella Infections (etiology) |
| 7 | Pasteurella Infections (drug therapy) |
| 7 | Lymph Nodes (microbiology) |
| 7 | Immunodeficiency Virus, Feline (physiology) |
| 7 | Hypersensitivity, Immediate (immunology) |
| 7 | Hypersensitivity (epidemiology) |
| 7 | Follow-Up Studies (MeSH) |
| 7 | Endocarditis, Bacterial (microbiology) |
| 7 | Dog Diseases (virology) |
| 7 | Cohort Studies (MeSH) |
| 7 | Cats (parasitology) |
| 7 | Cat-Scratch Disease (drug therapy) |
| 7 | COVID-19 (veterinary) |
| 7 | Bartonella henselae (classification) |
| 7 | Bartonella Infections (transmission) |
| 7 | Bartonella (classification) |
| 7 | Antibodies, Bacterial (blood) |
| 7 | Angiomatosis, Bacillary (microbiology) |
| 6 | Toxoplasma (isolation & purification) |
| 6 | Serotyping (MeSH) |
| 6 | Sequence Alignment (MeSH) |
| 6 | SARS-CoV-2 (MeSH) |
| 6 | Rural Population (MeSH) |
| 6 | Risk Assessment (MeSH) |
| 6 | Research (MeSH) |
| 6 | Population Surveillance (MeSH) |
| 6 | Polymerase Chain Reaction (methods) |
| 6 | Neurons (physiology) |
| 6 | Mutation (MeSH) |
| 6 | Immunohistochemistry (MeSH) |
| 6 | Human-Animal Bond (MeSH) |
| 6 | Feces (parasitology) |
| 6 | Double-Blind Method (MeSH) |
| 6 | Disease Outbreaks (MeSH) |
| 6 | Bartonella (isolation & purification) |
| 6 | Bartonella (genetics) |
| 6 | Algorithms (MeSH) |
| 5 | Virus Replication (MeSH) |
| 5 | United Kingdom (epidemiology) |
| 5 | Travel (MeSH) |
| 5 | Transfection (MeSH) |
| 5 | Toxoplasmosis, Animal (parasitology) |
| 5 | Toxoplasmosis, Animal (epidemiology) |
| 5 | Toxoplasmosis (complications) |
| 5 | Switzerland (MeSH) |
| 5 | Skin Tests (methods) |
| 5 | Severity of Illness Index (MeSH) |
| 5 | Seasons (MeSH) |
| 5 | Radioallergosorbent Test (MeSH) |
| 5 | RNA, Viral (genetics) |
| 5 | Polymorphism, Restriction Fragment Length (MeSH) |
| 5 | Pasteurella multocida (MeSH) |
| 5 | Pasteurella Infections (transmission) |
| 5 | Pasteurella Infections (microbiology) |
| 5 | Ownership (MeSH) |
| 5 | Mites (immunology) |
| 5 | Microbial Sensitivity Tests (MeSH) |
| 5 | Mice, Inbred C57BL (MeSH) |
| 5 | Macaca mulatta (MeSH) |
| 5 | Immunodeficiency Virus, Feline (genetics) |
| 5 | Immunocompromised Host (MeSH) |
| 5 | Hypersensitivity (diagnosis) |
| 5 | HeLa Cells (MeSH) |
| 5 | Germany (epidemiology) |
| 5 | Germany (MeSH) |
| 5 | Genome, Viral (MeSH) |
| 5 | Feline Acquired Immunodeficiency Syndrome (virology) |
| 5 | Enzyme-Linked Immunosorbent Assay (MeSH) |
| 5 | Electric Stimulation (MeSH) |
| 5 | Echinococcosis (transmission) |
| 5 | Dog Diseases (pathology) |
| 5 | Diagnosis, Differential (MeSH) |
| 5 | DNA, Ribosomal (genetics) |
| 5 | DNA, Bacterial (isolation & purification) |
| 5 | Ctenocephalides (microbiology) |
| 5 | Cross Reactions (MeSH) |
| 5 | Chickens (MeSH) |
| 5 | Cells, Cultured (MeSH) |
| 5 | Cats (virology) |
| 5 | Cat-Scratch Disease (pathology) |
| 5 | Cat Diseases (therapy) |
| 5 | Cat Diseases (surgery) |
| 5 | Cat Diseases (pathology) |
| 5 | Cat Diseases (drug therapy) |
| 5 | Bronchial Provocation Tests (MeSH) |
| 5 | Brain Mapping (MeSH) |
| 5 | Birds (MeSH) |
| 5 | Bartonella quintana (isolation & purification) |
| 5 | Bartonella henselae (physiology) |
| 5 | Bartonella Infections (veterinary) |
| 5 | Bartonella Infections (drug therapy) |
| 5 | Bacterial Typing Techniques (methods) |
| 5 | Bacteremia (microbiology) |
| 5 | Asthma (diagnosis) |
| 5 | Allergens (analysis) |
| 5 | Africa (MeSH) |
| 5 | Administration, Inhalation (MeSH) |
| 4 | Viral Envelope Proteins (genetics) |
| 4 | Transcription, Genetic (MeSH) |
| 4 | Toxoplasmosis (genetics) |
| 4 | Toxoplasma (physiology) |
| 4 | Toxoplasma (pathogenicity) |
| 4 | Soil (parasitology) |
| 4 | Siphonaptera (microbiology) |
| 4 | Sequence Homology, Amino Acid (MeSH) |
| 4 | Retinitis (etiology) |
| 4 | Respiratory Hypersensitivity (etiology) |
| 4 | Rabies virus (isolation & purification) |
| 4 | Rabies Vaccines (adverse effects) |
| 4 | Rabies (transmission) |
| 4 | Rabies (drug therapy) |
| 4 | Public Health (MeSH) |
| 4 | Protein Conformation (MeSH) |
| 4 | Prognosis (MeSH) |
| 4 | Photic Stimulation (MeSH) |
| 4 | Pets (parasitology) |
| 4 | Pets (microbiology) |
| 4 | Pets (MeSH) |
| 4 | Pasteurella multocida (drug effects) |
| 4 | Pasteurella Infections (diagnosis) |
| 4 | Pasteurella Infections (complications) |
| 4 | Neural Pathways (physiology) |
| 4 | Models, Molecular (MeSH) |
| 4 | Models, Animal (MeSH) |
| 4 | Mice, Inbred BALB C (MeSH) |
| 4 | Mammals (MeSH) |
| 4 | Magnetic Resonance Imaging (methods) |
| 4 | Leptospirosis (epidemiology) |
| 4 | Insect Vectors (microbiology) |
| 4 | Immunoglobulin E (analysis) |
| 4 | Immunization (MeSH) |
| 4 | Hypersensitivity, Immediate (epidemiology) |
| 4 | Hypersensitivity, Immediate (diagnosis) |
| 4 | History, Medieval (MeSH) |
| 4 | History, Ancient (MeSH) |
| 4 | History, 18th Century (MeSH) |
| 4 | HIV-1 (physiology) |
| 4 | Goats (MeSH) |
| 4 | Glycoproteins (immunology) |
| 4 | Geography (MeSH) |
| 4 | Genetic Vectors (MeSH) |
| 4 | Genes, env (MeSH) |
| 4 | Gene Products, gag (genetics) |
| 4 | Gene Products, env (genetics) |
| 4 | Environmental Exposure (adverse effects) |
| 4 | Endogenous Retroviruses (genetics) |
| 4 | Endocarditis, Bacterial (diagnosis) |
| 4 | Encephalopathy, Bovine Spongiform (transmission) |
| 4 | Encephalopathy, Bovine Spongiform (epidemiology) |
| 4 | Electroencephalography (MeSH) |
| 4 | Echinococcosis (epidemiology) |
| 4 | Dust (analysis) |
| 4 | Dose-Response Relationship, Drug (MeSH) |
| 4 | Dopamine (metabolism) |
| 4 | Dogs (parasitology) |
| 4 | Dog Diseases (prevention & control) |
| 4 | Dog Diseases (diagnosis) |
| 4 | Dermatitis, Atopic (epidemiology) |
| 4 | Computer Simulation (MeSH) |
| 4 | Cloning, Molecular (MeSH) |
| 4 | Chlorocebus aethiops (MeSH) |
| 4 | Chiroptera (MeSH) |
| 4 | Cats (physiology) |
| 4 | Cat-Scratch Disease (epidemiology) |
| 4 | Cat Diseases (prevention & control) |
| 4 | Carnivora (MeSH) |
| 4 | COVID-19 (epidemiology) |
| 4 | COS Cells (MeSH) |
| 4 | Brain (physiology) |
| 4 | Bites and Stings (microbiology) |
| 4 | Bartonella henselae (MeSH) |
| 4 | Bacterial Proteins (genetics) |
| 4 | Asthma (physiopathology) |
| 4 | Antigens, Dermatophagoides (MeSH) |
| 4 | Antibodies, Protozoan (blood) |
| 4 | Antibodies, Monoclonal (immunology) |
| 4 | Antibodies, Monoclonal (MeSH) |
| 4 | Antibodies, Bacterial (immunology) |
| 4 | Anti-Bacterial Agents (pharmacology) |
| 4 | Animals, Domestic (microbiology) |
| 4 | Alleles (MeSH) |
| 3 | Zoonoses (virology) |
| 3 | Zoonoses (prevention & control) |
| 3 | Visual Cortex (physiology) |
| 3 | Virus Replication (genetics) |
| 3 | Trench Fever (diagnosis) |
| 3 | Toxoplasmosis, Animal (transmission) |
| 3 | Toxoplasmosis (transmission) |
| 3 | Toxoplasmosis (psychology) |
| 3 | Toxoplasmosis (drug therapy) |
| 3 | Toxoplasma (growth & development) |
| 3 | Tissue Distribution (MeSH) |
| 3 | Tick Infestations (veterinary) |
| 3 | Spleen (pathology) |
| 3 | Spain (epidemiology) |
| 3 | Spain (MeSH) |
| 3 | South Africa (MeSH) |
| 3 | Sex Factors (MeSH) |
| 3 | Sequence Analysis, RNA (MeSH) |
| 3 | Selection, Genetic (MeSH) |
| 3 | Schizophrenia (parasitology) |
| 3 | SARS-CoV-2 (genetics) |
| 3 | Rodentia (parasitology) |
| 3 | Rodentia (MeSH) |
| 3 | Risk-Taking (MeSH) |
| 3 | Risk (MeSH) |
| 3 | Rhinitis, Allergic (immunology) |
| 3 | Rhinitis (epidemiology) |
| 3 | Respiratory Hypersensitivity (immunology) |
| 3 | Research Design (MeSH) |
| 3 | Renal Dialysis (adverse effects) |
| 3 | Recombination, Genetic (MeSH) |
| 3 | Recombinant Fusion Proteins (metabolism) |
| 3 | Receptors, Virus (genetics) |
| 3 | Real-Time Polymerase Chain Reaction (veterinary) |
| 3 | Real-Time Polymerase Chain Reaction (MeSH) |
| 3 | Rats, Sprague-Dawley (MeSH) |
| 3 | Pyroglyphidae (immunology) |
| 3 | Pyroglyphidae (MeSH) |
| 3 | Protein Binding (MeSH) |
| 3 | Prion Diseases (transmission) |
| 3 | Pregnancy Complications, Parasitic (epidemiology) |
| 3 | Poultry (MeSH) |
| 3 | Postoperative Complications (microbiology) |
| 3 | Polymorphism, Genetic (MeSH) |
| 3 | Polymerase Chain Reaction (veterinary) |
| 3 | Paris (MeSH) |
| 3 | Parasite Egg Count (MeSH) |
| 3 | Papilledema (etiology) |
| 3 | Oocysts (MeSH) |
| 3 | Odds Ratio (MeSH) |
| 3 | Neurons (drug effects) |
| 3 | Neural Pathways (anatomy & histology) |
| 3 | Muscle, Skeletal (physiology) |
| 3 | Muscle Contraction (physiology) |
| 3 | Motor Activity (physiology) |
| 3 | Meningitis, Bacterial (etiology) |
| 3 | Meningitis, Bacterial (drug therapy) |
| 3 | Meat (adverse effects) |
| 3 | Meat (MeSH) |
| 3 | Mass Spectrometry (MeSH) |
| 3 | Mammary Neoplasms, Animal (pathology) |
| 3 | Magnetic Resonance Imaging (MeSH) |
| 3 | Logistic Models (MeSH) |
| 3 | Leukocyte Count (MeSH) |
| 3 | Leishmaniasis, Visceral (veterinary) |
| 3 | Leishmaniasis, Visceral (epidemiology) |
| 3 | Leishmaniasis (veterinary) |
| 3 | Leishmaniasis (epidemiology) |
| 3 | Leishmania infantum (MeSH) |
| 3 | Lead (blood) |
| 3 | Langerhans Cells (virology) |
| 3 | Langerhans Cells (ultrastructure) |
| 3 | Langerhans Cells (immunology) |
| 3 | Immunoglobulin G (blood) |
| 3 | Immunodeficiency Virus, Feline (metabolism) |
| 3 | Immunodeficiency Virus, Feline (isolation & purification) |
| 3 | Ill-Housed Persons (MeSH) |
| 3 | Hypersensitivity, Immediate (etiology) |
| 3 | Host-Parasite Interactions (MeSH) |
| 3 | Horses (immunology) |
| 3 | HIV-1 (genetics) |
| 3 | HEK293 Cells (MeSH) |
| 3 | Gestational Age (MeSH) |
| 3 | Gene Products, gag (metabolism) |
| 3 | Gene Products, env (metabolism) |
| 3 | Foxes (parasitology) |
| 3 | Flea Infestations (microbiology) |
| 3 | Fever (etiology) |
| 3 | Ferrets (MeSH) |
| 3 | Fatal Outcome (MeSH) |
| 3 | Farms (MeSH) |
| 3 | Escherichia coli (genetics) |
| 3 | Epitopes (MeSH) |
| 3 | England (MeSH) |
| 3 | Electrophoresis, Polyacrylamide Gel (MeSH) |
| 3 | Electromyography (MeSH) |
| 3 | Ecosystem (MeSH) |
| 3 | Echocardiography (veterinary) |
| 3 | Echinococcus (isolation & purification) |
| 3 | Dust (MeSH) |
| 3 | Drug Therapy, Combination (MeSH) |
| 3 | Dogs (blood) |
| 3 | Dog Diseases (therapy) |
| 3 | Dog Diseases (surgery) |
| 3 | Dog Diseases (drug therapy) |
| 3 | Disease Reservoirs (microbiology) |
| 3 | Dirofilariasis (transmission) |
| 3 | Dirofilariasis (diagnosis) |
| 3 | Desensitization, Immunologic (MeSH) |
| 3 | Dermatitis, Atopic (immunology) |
| 3 | Dermatitis, Atopic (diagnosis) |
| 3 | DNA Primers (MeSH) |
| 3 | Creutzfeldt-Jakob Syndrome (transmission) |
| 3 | Cockroaches (immunology) |
| 3 | Cluster Analysis (MeSH) |
| 3 | Clinical Competence (MeSH) |
| 3 | Chiroptera (virology) |
| 3 | Cerebral Cortex (physiology) |
| 3 | Cattle Diseases (microbiology) |
| 3 | Cats (surgery) |
| 3 | Cats (psychology) |
| 3 | Cats (blood) |
| 3 | Cat-Scratch Disease (therapy) |
| 3 | Cat Diseases (etiology) |
| 3 | Cat Diseases (diagnostic imaging) |
| 3 | Carcinoma, Squamous Cell (pathology) |
| 3 | Capnocytophaga (MeSH) |
| 3 | COVID-19 Vaccines (MeSH) |
| 3 | COVID-19 (virology) |
| 3 | COVID-19 (transmission) |
| 3 | COVID-19 (MeSH) |
| 3 | Bronchial Hyperreactivity (immunology) |
| 3 | Brain (pathology) |
| 3 | Body Weight (MeSH) |
| 3 | Blotting, Western (MeSH) |
| 3 | Bites and Stings (prevention & control) |
| 3 | Biopsy (MeSH) |
| 3 | Biological Evolution (MeSH) |
| 3 | Bartonella henselae (pathogenicity) |
| 3 | Bartonella henselae (immunology) |
| 3 | Bartonella henselae (drug effects) |
| 3 | Bartonella Infections (complications) |
| 3 | Bacteriological Techniques (MeSH) |
| 3 | Bacterial Typing Techniques (MeSH) |
| 3 | Bacterial Proteins (metabolism) |
| 3 | Azithromycin (therapeutic use) |
| 3 | Asia (MeSH) |
| 3 | Antiviral Agents (pharmacology) |
| 3 | Antibodies, Protozoan (MeSH) |
| 3 | Animals, Wild (microbiology) |
| 3 | Angiomatosis, Bacillary (diagnosis) |
| 3 | Adaptation, Physiological (MeSH) |
| 2 | beta-Lactamases (genetics) |
| 2 | Zoonoses (genetics) |
| 2 | Wound Infection (etiology) |
| 2 | Wound Healing (MeSH) |
| 2 | World Health Organization (MeSH) |
| 2 | Wakefulness (physiology) |
| 2 | Waardenburg Syndrome (genetics) |
| 2 | Visual Pathways (physiology) |
| 2 | Visual Cortex (physiopathology) |
| 2 | Visual Acuity (MeSH) |
| 2 | Virus Shedding (MeSH) |
| 2 | Virus Assembly (MeSH) |
| 2 | Virulence (genetics) |
| 2 | Viral Vaccines (MeSH) |
| 2 | Viral Proteins (genetics) |
| 2 | Viral Envelope Proteins (metabolism) |
| 2 | Veterinarians (statistics & numerical data) |
| 2 | Veterinarians (MeSH) |
| 2 | Vaccination (veterinary) |
| 2 | Urticaria (etiology) |
| 2 | Urticaria (epidemiology) |
| 2 | Urodynamics (MeSH) |
| 2 | Urinary Bladder (physiology) |
| 2 | Urban Population (MeSH) |
| 2 | Urban Health (MeSH) |
| 2 | United States (epidemiology) |
| 2 | Trypanosoma cruzi (genetics) |
| 2 | Triple Negative Breast Neoplasms (pathology) |
| 2 | Triple Negative Breast Neoplasms (metabolism) |
| 2 | Triatoma (parasitology) |
| 2 | Trench Fever (transmission) |
| 2 | Trench Fever (microbiology) |
| 2 | Trench Fever (epidemiology) |
| 2 | Transcranial Magnetic Stimulation (MeSH) |
| 2 | Toxoplasmosis, Congenital (epidemiology) |
| 2 | Toxoplasmosis (immunology) |
| 2 | Toxoplasmosis (diagnosis) |
| 2 | Toxoplasma (MeSH) |
| 2 | Tomography, X-Ray Computed (MeSH) |
